Originally posted by Glyco
USA underwriter/UW was appointed on 20October. Do you think Mr. UW has been sleeping for last 3 months, and next 3 months?
Nasdaq *dual listing ( not IPO) is simply listing/retailing part of Gmv issued shares (plus potential new issues) to usa investors. Great exposure to some of America tech investors.
Don't you agree?
aimo
02,Oct 2018
"...
Mobile health device maker G Medical Innovations is to list on the NASDAQ exchange in the US.
G Medical (ASX:GMV) makes digital products that help monitor a person’s health.
Its ‘Prizma’ Medical Smartphone Case
turns a smartphone into a clinical grade mobile medical monitor to measure vital signs such as ECG, respiration, oxygen saturation, heart rate, temperature and stress analysis.
G Medical (ASX:GMV) told investors on Tuesday morning it had appointed an underwriter to smooth the pathway towards a US public offering in four to five months.
In an emailed statement to
*, a company spokesman said G Medical has a presence in the US and the NASDAQ is a favoured location for biotechs, so a move to the US exchange “suits the growth profile of the company”.
It is staying on the ASX..."
https://unauthorised investment adv...-to-america-in-a-dual-listing-via-the-nasdaq/
You can be informed, under-informed or mis-informed...
